Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
parameters used in animal studies are not validated for human use
Who Might Consider BPC-157 and Who Should Avoid It Based on the preclinical data and clinical patterns of use, the patient populations most commonly prescribed BPC-157 for GI indications include: patients with persistent NSAID gastropathy despite PPI therapy, patients with functional GI symptoms attributed to intestinal barrier dysfunction, and patients with inflammatory bowel disease who have not responded adequately to biologic therapy and seek adjunctive options
Plain English summary: dry freeze-dried peptides are more stable than liquid peptide solutions
You may not experience symptoms if you have a vitamin B12 deficiency right away
Seiwerth et al., Frontiers in Pharmacology (2021) and Xing et al., Int J Mol Sci (2021)
